Taken these together, our results suggested that the lower dose curcumin treatment might not induced sufficient downregulation of AURKA or CDK1 to inhibit proliferation of hepatocellular carcinoma cells. The gene discussed is CDK1; the disease is hepatocellular carcinoma.